tiprankstipranks
Trending News
More News >
Biovaxys Technology Corp (BVAXF)
:BVAXF
US Market

BioVaxys Technology (BVAXF) Income Statement

Compare
32 Followers

BioVaxys Technology Income Statement

Last quarter (Q1 2025), BioVaxys Technology's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, BioVaxys Technology's net income was C$-1.07M. See BioVaxys Technology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating Expenses
C$ 3.30MC$ 2.40MC$ 4.08MC$ 6.44MC$ 1.10M
Depreciation and Amortization
C$ 0.00C$ 2.40MC$ 3.80MC$ 39.47KC$ 8.62K
EBITDA
C$ -3.95MC$ -7.69MC$ 0.00C$ -6.42MC$ -1.09M
Operating Income
C$ -3.30MC$ -2.40MC$ -4.08MC$ -6.44MC$ -1.10M
Other Income/Expenses
C$ -659.26KC$ -5.28MC$ -7.65MC$ -15.91KC$ -4.24K
Pretax Income
C$ -3.95MC$ -7.69MC$ -11.73MC$ -6.46MC$ -1.10M
Net Income
C$ -3.95MC$ -7.69MC$ -11.73MC$ -6.46MC$ -1.17M
Per Share Metrics
Basic EPS
C$ -0.02C$ -0.06C$ -0.12C$ -0.08C$ -0.04
Diluted EPS
C$ -0.02C$ -0.06C$ -0.12C$ -0.08C$ -0.04
Weighted Average Shares Outstanding
195.72M 134.15M 98.18M 82.93M 30.05M
Weighted Average Shares Outstanding (Diluted)
195.72M 134.14M 98.18M 82.93M 28.21M
Currency in CAD

BioVaxys Technology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis